Marketing authorisation and market access in Türkiye

From authorisation
to market, we stand by your product.


Marketing authorisation, pricing, reimbursement and medical translation for human medicinal products, plus registration of medical devices, food supplements and cosmetics. For pharmaceutical companies in Türkiye and international pharmaceutical companies entering the Turkish market.

Your product's journey

  1. 01
    AuthorisationTİTCK marketing authorisation
  2. 02
    PricingReference price analysis and approval
  3. 03
    ReimbursementSGK reimbursement listing
  4. 04
    On the marketVariations, renewals, PIL and ePIL
20+ years of industry experience in our expert teamTİTCK · SGK authorisation, pricing, reimbursement15 service areasTR · EN bilingual service

About us

Marketing authorisation and market access consultancy

Melvin International Consulting is an Ankara-based consultancy supporting pharmaceutical, medical device, food supplement and cosmetics companies in Türkiye. We prepare and follow up marketing authorisation applications with TİTCK, manage pricing and SGK reimbursement processes, conduct PIL readability testing and provide medical translation, drawing on our expert team’s 20+ years of industry experience.

New to Türkiye? Read our guide to pharmaceutical market entry in Türkiye: who can hold the marketing authorisation, and the steps from application to price, sales authorisation and reimbursement.

Melvin in numbers

Since 2019

55+

client companies

700+

products in pricing and reimbursement

500+

translations

280+

PIL readability tests

200+

MA dossiers

15+

contracted clients

Figures reflect completed work in our job records and period price application files for 2019–2026, can be verified against those records and are rounded down. MA dossiers include export registration dossiers and module preparation. The pricing and reimbursement figure is based on the number of products our pricing and reimbursement clients have in the TİTCK price list. In line with our confidentiality principle, we do not disclose our clients’ names or projects.

Our services

From marketing authorisation
to market access

We support pharmaceutical, medical device, food supplement and cosmetics companies in Türkiye with end-to-end regulatory consultancy, from marketing authorisation, pricing and reimbursement to PIL readability testing and medical translation.

How we work

One team, one calendar, every stage

  1. 01

    Assessment

    We map the regulatory, pricing and reimbursement status of your product or portfolio and identify the applications needed.

  2. 02

    Planning

    We bring applications and deadlines into a single calendar and agree the dossier requirements with you.

  3. 03

    Preparation and submission

    We prepare the application dossiers in line with current legislation and follow the procedures on your behalf.

  4. 04

    Follow-up and reporting

    We handle correspondence with the authorities, respond to deficiency letters on time and keep you informed at every stage.

Expertise

A closer look at the processes

The Marketing Authorisation Process

In Türkiye, a marketing authorisation from the Turkish Medicines and Medical Devices Agency (TİTCK) is required to place a human medicinal product on the market. The application is submitted with a dossier in CTD format that demonstrates the quality, safety and efficacy of the product. We manage the entire process, from preparing the dossier through the preliminary review and evaluation stages and responses to committee questions, until the marketing authorisation is granted. After approval, we stay with you throughout the product lifecycle with variation, renewal and transfer applications.

Market Access: Pricing and Reimbursement

Marketing authorisation is only the first step towards reaching patients. The product then needs a price from TİTCK and a place on the Social Security Institution (SGK) reimbursement list. From reference country price research and actual source price calculations to SGK institutional discount analysis and the reimbursement dossier, we plan and run this process in line with your commercial objectives.

PIL Readability Testing

Marketing authorisation applications must show that the patient information leaflet (PIL) is understandable to patients. This is demonstrated not by calculating a readability score, but by user testing with participants who match the target user profile. Participants are asked product-specific questions to find and correctly understand information in the PIL; for each question, at least 16 of 20 participants are expected to succeed. We run the whole process from test design to reporting and, where appropriate, prepare a bridging report instead of a new test.

Why Melvin?

From application to market, under one roof

Because we offer marketing authorisation, pricing, reimbursement and translation services under one roof, your product benefits from a consistent approach at every stage, from the marketing authorisation application to market entry. With our expert team’s 20+ years of industry experience, we follow every stage from start to approval and keep you informed throughout.

20+ years of experience

Our expert team follows every stage from start to approval.

One calendar

Authorisation, pricing and reimbursement deadlines in a single plan; no period is missed.

Regular updates

We handle correspondence with the authorities and keep you informed at every stage.

Confidentiality

We do not disclose our clients’ names or projects.

Get in touch

Let’s plan the next steps for your product

Tell us about your product, its current regulatory and pricing status and your target timeline, and we will get back to you promptly.